Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A carotid body paraganglioma that metastasizes to other anatomic sites.
Biomarker and diagnostic research for malignant carotid body paraganglioma has been reported in the published literature.
No clinical trials have been registered for malignant carotid body paraganglioma.
106 publications have been identified in PubMed for malignant carotid body paraganglioma. Research spans Case Report / Case Series (37%), Clinical Trial Publication (22%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 39 | 37% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 4:52 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Clinical study results
23 |
22% |
Research summaries | 15 | 14% |
Testing and diagnosis research | 9 | 8% |
Laboratory research | 9 | 8% |
Disease patterns and progression | 8 | 8% |
New treatment approaches | 2 | 2% |
Other research | 1 | 1% |
Rohith S (2026). [PMID: 41909349](https://pubmed.ncbi.nlm.nih.gov/41909349/). *Cureus*. [Case Report / Case Series]
Hamimi SA (2026). [PMID: 41654216](https://pubmed.ncbi.nlm.nih.gov/41654216/). *World Neurosurg*. [Case Report / Case Series]
Kumar SA (2026). [PMID: 41954972](https://pubmed.ncbi.nlm.nih.gov/41954972/). *Clin Nucl Med*. [Diagnostic / Biomarker]
Li F (2026). [PMID: 42162491](https://pubmed.ncbi.nlm.nih.gov/42162491/). *Discov Oncol*. [Case Report / Case Series]
Wang YH (2026). [PMID: 40719354](https://pubmed.ncbi.nlm.nih.gov/40719354/). *Vascular*. [Review / Meta-Analysis]
Zorlu ME (2026). [PMID: 41243017](https://pubmed.ncbi.nlm.nih.gov/41243017/). *European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery*. [Clinical Trial Publication]
Huanggu H (2026). [PMID: 40692312](https://pubmed.ncbi.nlm.nih.gov/40692312/). *Head Neck*. [Case Report / Case Series]
Sauter C (2026). [PMID: 41195582](https://pubmed.ncbi.nlm.nih.gov/41195582/). *Head & neck*. [Epidemiology / Natural History]
Aggarwal P (2026). [PMID: 40310021](https://pubmed.ncbi.nlm.nih.gov/40310021/). *Clinical nuclear medicine*. [Gene Therapy / Novel Therapeutics]
Ikram A (2026). [PMID: 31751024](https://pubmed.ncbi.nlm.nih.gov/31751024/). *Unknown Journal*. [Review / Meta-Analysis]
AI-curated news mentioning malignant carotid body paraganglioma
Updated Aug 28, 2026
A recent case report details a patient with metastatic carotid body paraganglioma that exhibited indolent growth over 30 years. This case highlights the potential for long-term monitoring in patients with this rare tumor type.